Patents Assigned to Bioneer Corporation
-
Publication number: 20190227091Abstract: A biological sample processing apparatus, including: a pipette block with which a plurality of pipettes for sucking or discharging a biological sample in a multi-well plate in which wells are arranged in a matrix shape along row and column directions are detachably coupled; a pipette block forward and backward transfer unit configured to move the pipette block along a forward and backward direction along a process direction; a pipette block top and bottom transfer unit configured to move the pipette block along a vertical direction; a magnetic field applying unit disposed below the multi-well plate for applying a magnetic field to a well of the multi-well plate; and a heating unit disposed below the multi-well plate so as to be spaced apart from the magnetic field applying unit, for heating a well of the multi-well plate.Type: ApplicationFiled: September 28, 2017Publication date: July 25, 2019Applicant: BIONEER CORPORATIONInventors: Han Oh PARK, Yang Won LEE, Jin IL LEE, Jung Do KIM, Dae Jin JANG, Jong Kab KIM
-
Patent number: 10351849Abstract: The present invention relates to a pharmaceutical composition for treatment of cancer, which comprises, as an active ingredient, one or more miRNAs selected from the group consisting of miR-3670, miR-8078, and miR-4477a. The pharmaceutical composition for treatment of cancer according to the present invention exhibits excellent effects of inhibiting cancer cell proliferation and inducing cancer cell apoptosis. Thus, the pharmaceutical composition of the present invention can be effectively used as an anticancer therapeutic agent.Type: GrantFiled: February 25, 2016Date of Patent: July 16, 2019Assignee: BIONEER CORPORATIONInventors: Taewoo Lee, Sanghyung Shim, Ungsik Yu, Han Oh Park
-
Patent number: 10287542Abstract: An automated cell-free protein production system comprises: a protein expression reaction unit comprising a reaction vessel that includes a plurality of dialysis tubes, each including a dialysis membrane and being open at its top; a reaction temperature control unit configured to heat or cool the reaction vessel; a pipette array comprising a plurality of pipettes and configured to suck or discharge solutions using the pipettes; a pipette array moving unit configured to move the pipette array in an upward and downward direction, a forward and backward direction or a left and right direction so as to move solutions; a protein purification unit including a magnetic field application device; and a multi-well plate mounting unit having mounted therein a multi-well plate kit configured to supply solutions that are used for protein production.Type: GrantFiled: November 29, 2013Date of Patent: May 14, 2019Assignee: BIONEER CORPORATIONInventors: Han Oh Park, Jong Kab Kim, Ji Won Han, You Sang Cho, Min Jung Kim, Ha Neul Kim, Yang Won Lee, Nam Il Kim
-
Patent number: 10249404Abstract: A ceramic paste composition including carbon nanotubes or a carbon nanotube-metal composite and a silicone adhesive, wherein the silicone adhesive includes 0.1 to 10 wt % of a silanol group, and has a mole ratio of a phenyl group to a methyl group of 0.3 to 2.5. The ceramic paste composition has low sheet resistance, through which an excellent heat generating property, and shielding, absorbing and conducting properties may be implemented in one or more embodiments. Further, though the ceramic paste composition has a very high heat generating temperature of 400° C., as compared with general paste based on carbon nanotubes, the physical properties thereof may be maintained stably. In addition, the ceramic paste may be widely used in various fields including heat generating products such as those for keeping warmth or heating, and products for electromagnetic wave shielding and absorption, electrodes, electronic circuits, antennas, and the like.Type: GrantFiled: July 9, 2014Date of Patent: April 2, 2019Assignee: BIONEER CORPORATIONInventors: Han Oh Park, Jae Ha Kim, Jun Pyo Kim
-
Publication number: 20190076843Abstract: Provided is a low heat capacity composite for a thermal cycler. The low heat capacity composite of the present invention is a low heat capacity composite for a thermal cycler capable of overcoming difficulty in manufacture and reproducibility due to uniqueness of the existing PCR thermal cycler only. The low heat capacity composite of the present invention can reduce the cost of raw material and retain excellent heat property due to the improvement in low heat capacity and physical and mechanical properties, thereby remarkably shortening PCR reaction time and saving energy when used as a thermal block for a thermal cycler.Type: ApplicationFiled: November 12, 2018Publication date: March 14, 2019Applicant: BIONEER CORPORATIONInventors: Han Oh PARK, Jae Ha KIM
-
Patent number: 10208309Abstract: The present invention relates to a novel siRNA, and a high-efficiency double-stranded oligo RNA structure containing the same, and a nanoparticle containing the high-efficiency double-stranded oligo RNA structure. The double-stranded oligo RNA structure has a structure in which a hydrophilic material and a hydrophobic material are conjugated to both ends of a double-stranded oligo RNA (siRNA) via a simple covalent bond or linker-mediated covalent bond in order to be efficiently delivered into cells, and may be converted into a nanoparticle form in an aqueous solution by hydrophobic interactions of double-stranded oligo RNA structures. It is preferable that the siRNA contained in the double-stranded oligo RNA structure is an siRNA specific for fibrosis or respiratory disease-related gene, particularly, amphiregulin or stratifin.Type: GrantFiled: April 6, 2015Date of Patent: February 19, 2019Assignee: BIONEER CORPORATIONInventors: Jeiwook Chae, Pyoung Oh Yoon, Boram Han, Mi Na Kim, Youngho Ko, Han Oh Park
-
Patent number: 10167391Abstract: The present invention provides a novel azo compound having a quenching ability for the material that exhibits a luminescent phenomenon at an excited energy level, a quencher comprising the novel azo compound, a use of the quencher and a method for preparing the azo compound. The quencher according to the present invention may exhibit excellent characteristics in a wavelength absorption region.Type: GrantFiled: August 2, 2013Date of Patent: January 1, 2019Assignee: BIONEER CORPORATIONInventors: Sun Gi Kim, Taewoo Kwon, Jung Yung Choi
-
Patent number: 10144972Abstract: A composition for hot-start reverse transcription reaction and a composition for reverse transcription PCR are disclosed. The composition is obtained by adding pyrophosphate and pyrophosphatase to an aqueous solution containing reaction buffer solution, MgCl2, four kinds of dNTPs, and reverse transcription polymerase in a single reaction tube. The composition for hot-start reverse transcription reaction is obtained by freezing or drying the composition. The composition show increased stability and long-term storage stability. Also, disclosed is a composition that additionally includes DNA polymerase, and, thus, enables a hot-start reverse transcription reaction and a PCR reaction to be sequentially performed. A method for amplifying a nucleic acid by using the composition. The composition of the invention can be conveniently and effectively used in multiplex reverse transcription PCRs or real-time quantitative reverse transcription PCR.Type: GrantFiled: March 11, 2013Date of Patent: December 4, 2018Assignee: BIONEER CORPORATIONInventors: Han Oh Park, Jun Hee Lee, Sora Choi, Hyun Seo Kim
-
Patent number: 10030243Abstract: The present invention relates to an oligonucleotide structure and a method for preparing the same and, more particularly, to an oligonucleotide structure in which a polymer compound is linked to an oligonucleotide via a covalent bond to improve in vivo stability of the oligonucleotide and cellular delivery efficiency of the oligonucleotide; and to a method for preparing the same.Type: GrantFiled: July 4, 2014Date of Patent: July 24, 2018Assignee: BIONEER CORPORATIONInventors: Han Oh Park, Jeiwook Chae, Pyoung Oh Yoon, Boram Han, Gi-Eun Choi, Youngho Ko, Taewoo Kwon, Jae Don Lee, Sun Gi Kim
-
Patent number: 10022717Abstract: A method of manufacturing a micro-chamber plate with a built-in sample, including: settling a micro-chamber plate for sample injection at a micro-chamber plate receiving part formed with an upper opening; disposing a cover for micro-chamber plate receiving part to cover the upper opening, the cover for micro-chamber plate receiving part having a provisional storing part and an auxiliary covering part connected with the provisional storing part and formed with a through-hole for auxiliary covering part; and manufacturing a micro-chamber plate with a built-in sample by putting the micro-chamber plate receiving part, on which the cover is disposed, into a centrifugal separator which can apply vacuum, applying centrifugal force and injecting a sample solution provisionally stored in the provisional storing part into the micro-chamber plate through a vessel communication part which is formed at the provisional storing part to be communicated with the micro-chamber plate receiving part.Type: GrantFiled: October 5, 2015Date of Patent: July 17, 2018Assignee: BIONEER CORPORATIONInventors: Han Oh Park, Gu Young Song, Jung A Bae
-
Patent number: 9850530Abstract: The present invention relates to an automatic real-time quantitative amplification system which can perform analysis of various biological samples, and more particularly to an automatic real-time quantitative amplification system in which a plurality of decks for respectively accommodating biological samples are put in a deck storing/transferring device, whereby it is possible to automatically analyze an amount or existence of a target substance containing a target nucleic acid in the biologic sample, such as a particular gene, a particular, a particular pathogenic bacterium and a particular protein, by amplifying the target nucleic acid purified by some processes of purification, purification after culture, or purification after reaction of the target substance contained in the biological sample and then checking an amount of the amplified target nucleic acid.Type: GrantFiled: October 27, 2011Date of Patent: December 26, 2017Assignee: BIONEER CORPORATIONInventors: Han Oh Park, Kwon Sic Kim, Yang Won Lee, Jin Il Lee, Byung Rae Jeong, Jong Hoon Kim
-
Patent number: 9765383Abstract: Provided are an apparatus and a method for automatically analyzing biological samples capable of performing the entire processes of dissolving the biological samples in protease and cell lysate to dissolve a nucleic acid in a solution, attaching the nucleic acid to magnetic particles, finally washing the magnetic particle to which the nucleic acid is attached with an organic solvent, drying the magnetic particles using a vacuum pump, eluting the target nucleic acid attached to the magnetic particles in an aqueous solution, adding and mixing the eluted target nucleic acid into a vessel containing a nucleic acid amplification reagent, real-time detecting amplification by irradiating excitation light to a reactor simultaneously with regulating a temperature to perform amplification to measure fluorescence, inactivating an amplified product using an ultraviolet lamp after amplification, obtaining an image through electrophoresis, and analyzing a molecular weight in a single apparatus.Type: GrantFiled: February 7, 2013Date of Patent: September 19, 2017Assignee: BIONEER CORPORATIONInventors: Han Oh Park, Yang Won Lee, Jong-Kab Kim
-
Patent number: 9695421Abstract: The present invention relates to a dengue virus-specific siRNA, a double-stranded oligo RNA structure comprising the siRNA, and a composition for inhibiting dengue virus replication, which comprises the same, in which the double-stranded oligo RNA structure comprises a hydrophilic compound and hydrophobic compound conjugated to both ends of the double-stranded RNA (siRNA) by a single covalent bond or a linker-mediated covalent bond so that they will be efficiently delivered into cells, and can be converted into nanoparticles by hydrophobic interactions between the double-stranded oligo RNA structures in an aqueous solution. The siRNA included in the double-stranded oligo RNA structure acts specifically on all dengue virus serotypes. The present invention also relates to a method for preparing the double-stranded oligo RNA structure, and a pharmaceutical composition for preventing or treating dengue virus infection, which comprises the double-stranded oligo RNA structure.Type: GrantFiled: July 4, 2014Date of Patent: July 4, 2017Assignee: BIONEER CORPORATIONInventors: Joo Sung Yang, Woo Seok Kim, Soon Ja Choi, Han Oh Park
-
Patent number: 9649388Abstract: Provided are a SAMiRNA-magnetic nanoparticle complex capable of effectively delivering a double-stranded oligo RNA and magnetic nanoparticles into a cell and a composition capable of simultaneously performing diagnosis and therapy of diseases such as cancer, and the like, containing the same. More specifically, provided is the SAMiRNA-magnetic nanoparticle complex consisting of double-stranded oligo RNA-polymer structures in which a hydrophilic material and a second hydrophobic material are bound to the double-stranded oligo RNA by a simple covalent bond or a linker-mediated covalent bond, and the magnetic nanoparticles in which a first hydrophobic material is bound onto a surface of the magnetic material, as a core. The SAMiRNA-magnetic nanoparticle complex may have a homogeneous size by a hydrophobic interaction between the first hydrophobic material of the present invention and the second hydrophobic material of the double-stranded oligo RNA structure.Type: GrantFiled: January 17, 2013Date of Patent: May 16, 2017Assignee: BIONEER CORPORATIONInventors: Jeiwook Chae, Hyunjin Chung, Boreum Lee, Han Oh Park
-
Publication number: 20170016050Abstract: The present invention provides a novel azo compound having a quenching ability for the material that exhibits a luminescent phenomenon at an excited energy level, a quencher comprising the novel azo compound, a use of the quencher and a method for preparing the azo compound. The quencher according to the present invention may exhibit excellent characteristics in a wavelength absorption region.Type: ApplicationFiled: August 2, 2013Publication date: January 19, 2017Applicant: BIONEER CORPORATIONInventors: Sun Gi Kim, Taewoo Kwon, Jung Yung Choi
-
Patent number: 9534210Abstract: The present invention relates to a reverse transcriptase having improved thermostability, more precisely a mutant reverse transcriptase with improved thermostability by substitution of one or more amino acids selected from the group consisting of the 63rd glutamine (Q63), the 264th lysine (K264), the 295th lysine (K295), the 306th threonine (T306), the 346th glutamic acid (E346), the 408th proline (P408), the 438th histidine (H438), and the 454th asparagin (N454) of the amino acid sequence of M-MLV originated reverse transcriptase represented by SEQ. ID. NO: 1 with other amino acids. The mutant reverse transcriptase of the present invention demonstrates excellent thermostability, compared with the wild type reverse transcriptase. Therefore, it is advantageous to obtain the target cDNA with stable reverse transcription activity even in the presence of RNA that can form the stable secondary structure at a high temperature.Type: GrantFiled: February 7, 2012Date of Patent: January 3, 2017Assignee: BIONEER CORPORATIONInventors: Han Oh Park, Sung Jun Yang, Sung Mo Joo, Byoung Oh Hwang
-
Publication number: 20160368001Abstract: The present invention relates to a magnetic particle separating device, and a method of separating and purifying nucleic acid or protein using the same. The device comprises: induction magnets (100); an induction magnet fixing part (200) having induction magnet fixing holes (210) for fixing the induction magnets (100); and a body (300) in which entry holes (310) are formed into which tubes (T) are inserted. Thus, the application and removal of a magnetic field to and from the body is made very convenient, so that the device can be very advantageously used in the separation and purification of nucleic acid or protein.Type: ApplicationFiled: December 5, 2014Publication date: December 22, 2016Applicant: BIONEER CORPORATIONInventors: Han Oh PARK, Jong Kab KIM
-
Publication number: 20160145622Abstract: The present invention relates to a dengue virus-specific siRNA, a double-stranded oligo RNA structure comprising the siRNA, and a composition for inhibiting dengue virus replication, which comprises the same, in which the double-stranded oligo RNA structure comprises a hydrophilic compound and hydrophobic compound conjugated to both ends of the double-stranded RNA (siRNA) by a single covalent bond or a linker-mediated covalent bond so that they will be efficiently delivered into cells, and can be converted into nanoparticles by hydrophobic interactions between the double-stranded oligo RNA structures in an aqueous solution. The siRNA included in the double-stranded oligo RNA structure acts specifically on all dengue virus serotypes. The present invention also relates to a method for preparing the double-stranded oligo RNA structure, and a pharmaceutical composition for preventing or treating dengue virus infection, which comprises the double-stranded oligo RNA structure.Type: ApplicationFiled: July 4, 2014Publication date: May 26, 2016Applicant: BIONEER CORPORATIONInventors: Joo Sung Yang, Woo Seok Kim, Soon Ja Choi, Han Oh Park
-
Patent number: 9326941Abstract: Provided are a double-stranded oligo RNA structure and a method of preparing the same, and more specifically, a double-stranded oligo RNA structure in which a polymer compound is covalently bound to a double-stranded oligo RNA in order to improve stability in vivo and a cell delivery efficiency of the double-stranded oligo RNA, and a method of preparing the same. The double-stranded oligo RNA structure having the optimized structure according to the present invention may not inhibit functions of the double-stranded oligo RNA, but effectively improve stability and cell membrane permeability of the double-stranded oligo RNA, such that the double-stranded oligo RNA may be delivered into the cell even at a low concentration dosage thereof to be significantly used as a tool for treatment of cancer, infectious diseases, and the like, as well as a new delivery system of the double-stranded oligo RNA.Type: GrantFiled: January 4, 2013Date of Patent: May 3, 2016Assignee: BIONEER CORPORATIONInventors: Jeiwook Chae, Boram Han, Han-na Kim, Han Oh Park
-
Patent number: RE46912Abstract: The present invention relates to a lactic acid bacterium isolated from human mother's milk, more precisely a Lactobacillus gasseri BNR17 strain that is isolated from Korean mother's milk and has excellent probiotic activity including acid resistance, bile acid resistance and antimicrobial activity and weight gaining inhibitory effect as well. Again, the Lactobacillus gasseri BNR17 of the present invention has excellent acid resistance, bile acid resistance, enteric absorption activity and antimicrobial activity against pathogenic microorganisms, in addition to the weight gaining inhibitory effect by synthesizing indigestible polysaccharides from monosaccharides included in food taken and releasing the synthesized polysaccharides out of the body.Type: GrantFiled: November 10, 2014Date of Patent: June 26, 2018Assignee: BIONEER CORPORATIONInventors: Ji Hee Kang, Byeung I. You, Sung I. Yun, Han O. Park